Literature DB >> 7785677

Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization.

N J Talley1, A R Zinsmeister, L J Melton.   

Abstract

The clinical relevance of subdividing the irritable bowel syndrome (IBS) into subgroups based on bowel habit is largely unknown. We therefore obtained an age- and sex-stratified random sample of Olmsted County, Minnesota, residents aged 20-95 years. All subjects were mailed a valid self-report questionnaire during the years 1988-1993; the response rate was 74% (n = 3,022). Among subjects with IBS (n = 536), four symptom-based subgroups of similar size were identified: constipation predominant, diarrhea predominant, alternating constipation and diarrhea, and neither. The prevalence of IBS was significantly greater in females, primarily because of a higher prevalence of constipation-predominant IBS in women. Of persons > or = 60 years of age, 23% reported the initial onset of IBS in the previous year compared with 10% in younger subjects; the age at onset of IBS was similar among the subgroups. Marital status, education level, smoking, and alcohol use were not significantly different among the subgroups. Of those with IBS, 25% reported visiting a physician for abdominal pain or disturbed defecation in the prior year compared with only 8% of persons without IBS. Female sex, an increased number of Manning's symptom criteria, and the individual IBS subgroups were not associated with higher rates of physician visits. We conclude that the onset of IBS may not be limited to early adulthood and that subgroups of IBS based on bowel patterns may not identify clinically distinct entities.

Entities:  

Mesh:

Year:  1995        PMID: 7785677     DOI: 10.1093/oxfordjournals.aje.a117548

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  74 in total

1.  Irritable bowel syndrome: patterns of ambulatory health care and resource use in the United States, 1993-1997.

Authors:  Jennifer Hollowell; Annika Lundgren; Saga Johansson
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

2.  Prevalence, impact and attitudes toward lower gastrointestinal dysmotility and sensory symptoms, and their treatment in Canada: A descriptive study.

Authors:  Richard H Hunt; Surinder Dhaliwal; Gervais Tougas; Carmen Pedro; Jean-Francois Labbé; Heidi Paul; Michael Ennamorato
Journal:  Can J Gastroenterol       Date:  2007-01       Impact factor: 3.522

Review 3.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

4.  Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study.

Authors:  M A McNally; G R Locke; A R Zinsmeister; C D Schleck; J Peterson; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

5.  Canadian Digestive Health Foundation Public Impact Series 3: irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact.

Authors:  Richard N Fedorak; Stephen J Vanner; William G Paterson; Ron J Bridges
Journal:  Can J Gastroenterol       Date:  2012-05       Impact factor: 3.522

6.  Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source.

Authors:  Michel Bouchoucha; Marinos Fysekidis; Chantal Julia; Gheorghe Airinei; Jean-Marc Catheline; Gérard Reach; Robert Benamouzig
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

7.  The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome.

Authors:  J Alexander Cole; Jason M Yeaw; Jennifer A Cutone; Braden Kuo; Zhiping Huang; David L Earnest; Alexander M Walker
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 8.  New treatments for irritable bowel syndrome in women.

Authors:  Mopelola A Adeyemo; Lin Chang
Journal:  Womens Health (Lond)       Date:  2008-11

9.  Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age.

Authors:  Elyse R Thakur; Brian M Quigley; Hashem B El-Serag; Gregory D Gudleski; Jeffrey M Lackner
Journal:  J Psychosom Res       Date:  2016-07-16       Impact factor: 3.006

10.  Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

Authors:  Xavier Badia; Fermin Mearin; Agustin Balboa; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Mentse Roset; Nicholas J Talley
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.